An NK-like CAR T cell transition in CAR T cell dysfunction

Area of Science:

• Immunotherapy
• Cancer Biology
• Cellular Plasticity

Background:

• Chimeric antigen receptor (CAR) T-cell therapy is highly effective against blood cancers but faces challenges in solid tumors, largely due to T-cell exhaustion within the tumor microenvironment.
• Understanding the mechanisms of CAR T-cell dysfunction is crucial for advancing cancer treatment strategies.

Purpose of the Study:

• To investigate the dysfunction of mesothelin-redirected CAR T-cells in pancreatic cancer.
• To identify key regulators of CAR T-cell exhaustion and explore strategies to enhance therapeutic efficacy in solid tumors.

Main Methods:

• Development of a robust in vitro model of continuous antigen exposure to mimic T-cell exhaustion.
• Analysis of CAR T-cells from both in vitro models and patients with pancreatic cancer.
• Identification of gene expression signatures and transcription factors associated with CAR T-cell dysfunction.

Main Results:

• CAR T-cell exhaustion in solid tumors is linked to a transition from CD8+ T-cells to NK-like T-cells.
• A specific gene signature and transcription factors, SOX4 and ID3, were identified as critical regulators of CAR T-cell exhaustion.
• Genetic downregulation of ID3 and SOX4 was shown to improve CAR T-cell efficacy by mitigating dysfunction.

Conclusions:

• Human CAR T-cells exhibit significant plasticity, transitioning to an NK-like phenotype under continuous antigen exposure.
• SOX4 and ID3 are key drivers of CAR T-cell exhaustion and represent potential therapeutic targets.
• Modulating SOX4 and ID3 expression offers a promising strategy to enhance CAR T-cell therapy for solid tumors.